• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thalidomide Treatment for Thrombocytopenia Secondary to Hypersplenism in Children with Transfusion-Dependent β-Thalassemia: A Case Series.

作者信息

Gong Xiaoqing, Xiao Jian, Kong Wenqiang, Liu Xiaodong, Yang Kun

机构信息

Department of Pharmacy, Zigong First People's Hospital, Zigong, China.

Department of Hematology, Zigong First People's Hospital, Zigong, China.

出版信息

Mediterr J Hematol Infect Dis. 2025 May 1;17(1):e2025037. doi: 10.4084/MJHID.2025.037. eCollection 2025.

DOI:10.4084/MJHID.2025.037
PMID:40375905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12081042/
Abstract
摘要

相似文献

1
Thalidomide Treatment for Thrombocytopenia Secondary to Hypersplenism in Children with Transfusion-Dependent β-Thalassemia: A Case Series.沙利度胺治疗依赖输血的β地中海贫血患儿脾功能亢进继发血小板减少症：病例系列
Mediterr J Hematol Infect Dis. 2025 May 1;17(1):e2025037. doi: 10.4084/MJHID.2025.037. eCollection 2025.
2
Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia.沙利度胺用于治疗肝硬化或地中海贫血患者的血小板减少症和脾功能亢进。
Front Pharmacol. 2020 Jul 24;11:1137. doi: 10.3389/fphar.2020.01137. eCollection 2020.
3
Efficacy and Safety of Thalidomide in Patients With Transfusion-Dependent Thalassemia.沙利度胺治疗输血依赖型地中海贫血的疗效和安全性。
Indian Pediatr. 2021 Jul 15;58(7):611-616.
4
Clinical efficacy of thalidomide for various genotypes of beta thalassemia.沙利度胺治疗各种基因型β地中海贫血的临床疗效。
BMC Med Genomics. 2024 Jul 18;17(1):191. doi: 10.1186/s12920-024-01963-y.
5
Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study.沙利度胺治疗依赖输血的儿童β地中海贫血的疗效：一项回顾性临床研究
Front Pharmacol. 2021 Aug 12;12:722502. doi: 10.3389/fphar.2021.722502. eCollection 2021.
6
A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients.成人依赖输血的β地中海贫血患者中，单药羟基脲与沙利度胺对比的2期随机对照试验。
Indian J Hematol Blood Transfus. 2023 Apr;39(2):266-275. doi: 10.1007/s12288-022-01620-3. Epub 2023 Jan 3.
7
Partial splenic embolization in beta-thalassemia major. A case report.重型β地中海贫血的部分脾栓塞：一例报告
Turk J Pediatr. 2000 Jan-Mar;42(1):76-9.
8
Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.羟脲联合小剂量沙利度胺治疗输血依赖型β地中海贫血患者的经验。
Ann Hematol. 2021 Jun;100(6):1417-1427. doi: 10.1007/s00277-021-04501-3. Epub 2021 Apr 3.
9
Thalidomide has a significant effect in patients with thalassemia intermedia.沙利度胺对中间型地中海贫血患者有显著疗效。
Hematology. 2018 Jan;23(1):50-54. doi: 10.1080/10245332.2017.1354427. Epub 2017 Jul 18.
10
Thalidomide in Patients with Transfusion-Dependent E-Beta Thalassemia Refractory to Hydroxyurea: A Single-Center Experience.沙利度胺用于对羟基脲耐药的输血依赖型β地中海贫血患者：单中心经验
Indian J Hematol Blood Transfus. 2020 Apr;36(2):399-402. doi: 10.1007/s12288-020-01263-2. Epub 2020 Mar 2.

本文引用的文献

1
Effects of Thalidomide on Endothelial Activation and Stress Index in Children with β-Thalassemia Major.沙利度胺对重型β地中海贫血患儿内皮细胞活化及应激指标的影响
Mediterr J Hematol Infect Dis. 2024 Nov 1;16(1):e2024076. doi: 10.4084/MJHID.2024.076. eCollection 2024.
2
Effects of Thalidomide on Erythropoiesis and Iron Homeostasis in Transfusion-Dependent β-Thalassemia.沙利度胺对依赖输血的β地中海贫血患者红细胞生成及铁稳态的影响
Mediterr J Hematol Infect Dis. 2024 Jan 1;16(1):e2024001. doi: 10.4084/MJHID.2024.001. eCollection 2024.
3
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia.
β-地中海贫血和血红蛋白 E/β-地中海贫血的临床分类、筛查和诊断。
Hematol Oncol Clin North Am. 2023 Apr;37(2):313-325. doi: 10.1016/j.hoc.2022.12.003.
4
Thalassaemia.地中海贫血症。
Lancet. 2022 Jun 18;399(10343):2310-2324. doi: 10.1016/S0140-6736(22)00536-0. Epub 2022 Jun 9.
5
Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent -Thalassemia.沙利度胺治疗依赖输血的β地中海贫血患者后肝脏铁负荷及体积变化的磁共振成像定量分析
Front Pharmacol. 2022 Feb 18;13:810668. doi: 10.3389/fphar.2022.810668. eCollection 2022.
6
Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial.沙利度胺治疗输血依赖型β-地中海贫血患者的安全性和有效性：一项随机临床试验。
Signal Transduct Target Ther. 2021 Nov 18;6(1):405. doi: 10.1038/s41392-021-00811-0.
7
Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia.沙利度胺用于治疗肝硬化或地中海贫血患者的血小板减少症和脾功能亢进。
Front Pharmacol. 2020 Jul 24;11:1137. doi: 10.3389/fphar.2020.01137. eCollection 2020.
8
Thalidomide prevents antibody-mediated immune thrombocytopenia in mice.沙利度胺可预防小鼠抗体介导的免疫性血小板减少症。
Thromb Res. 2019 Nov;183:69-75. doi: 10.1016/j.thromres.2019.09.035. Epub 2019 Oct 22.
9
Thrombocytopenia: an update.血小板减少症：最新进展。
Int J Lab Hematol. 2014 Jun;36(3):269-78. doi: 10.1111/ijlh.12214.
10
The importance of spleen, spleen iron, and splenectomy for determining total body iron load, ferrikinetics, and iron toxicity in thalassemia major patients.脾脏、脾铁和脾切除术在确定地中海贫血患者体内总铁负荷、铁代谢动力学和铁毒性中的重要性。
Toxicol Mech Methods. 2013 Jan;23(1):34-41. doi: 10.3109/15376516.2012.735278.